Switch Energy Drink, a trailblazer in the energy beverage industry, is thrilled to announce a groundbreaking collaboration with Biogen South Africa, a premium wellness brand renowned for its high ...

The European Medicines Agency said Thursday that its committee evaluating medical products has recommended partial approval ...

The question now for Biogen is whether that difference is sufficiently compelling to encourage patients to switch from Tecfidera, or to start with Vumerity rather than one of its rival therapies.

We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis ...

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA ...

Oct 28 (Reuters) - Biogen (BIIB.O), opens new tab said on Monday insider Robin Kramer will take over as the drugmaker's finance chief after incumbent Michael McDonnell retires at the end of ...

CAMBRIDGE, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced upcoming data presentations and programming at the Clinical Trials on Alzheimer’s Disease (CTAD ...